Related Experiment Video
Updated: Aug 18, 2025

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Dilated Cardiomyopathy in Children: Early Detection and Treatment
Amrita Mallavarapu1, Amar Taksande2,3
1Department of Paediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.
Insights
Dilated cardiomyopathy (DCM) involves heart enlargement and poor contractility, often leading to heart failure. Early detection and treatment, including heart transplantation, are crucial for managing this condition.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Cardiomyopathy presents as primary or secondary, with dilated cardiomyopathy (DCM) characterized by cardiac dilatation and impaired contractility.
- Pediatric DCM involves dilated, contracting left ventricular defects and is associated with heart failure, stemming from various genetic and acquired causes.
Purpose of the Study:
- To review diagnostic methods for dilated cardiomyopathy (DCM).
- To highlight available treatment modalities for DCM.
Main Methods:
- Literature review of cardiomyopathy classifications and phenotypes.
- Analysis of diagnostic indicators for DCM, including imaging and clinical signs.
- Overview of current and potential treatment strategies for DCM.
Main Results:
- DCM manifests as left ventricular thinning, dilatation, systolic/diastolic dysfunction, and cardiomegaly, leading to symptoms like fatigue and dyspnea.
- Rare forms like left ventricular non-compaction cardiomyopathy (LVNC) are linked to specific genetic mutations (DSG2, TBX20).
- Complications include arrhythmias and thromboembolism, with heart transplantation as a definitive treatment for advanced DCM.
Conclusions:
- Dilated cardiomyopathy encompasses diverse causes and presentations, significantly impacting cardiac function and overall health.
- Accurate diagnosis through various methods is essential for effective management.
- Heart transplantation remains a vital option for end-stage DCM, underscoring the importance of ongoing research and treatment advancements.
Abstract:
Cardiomyopathy is segregated into primary and secondary categories, leading to different phenotypes, including dilated, hypertrophic, and restrictive patterns. Dilated cardiomyopathy (DCM) is a mixed bag of heart diseases with the unique features of cardiac dilatation and subnormal to poor myocardial contractility. Dilated cardiomyopathy in the pediatric age group is generally characterized by unobstructed, dilated, and contracting left ventricular chamber defects and is associated with heart failure. Other causes include genetic juvenile-onset cardiomyopathy, drug-induced cardiomyopathy, stress-induced cardiomyopathy, hemochromatosis, endocrine causes (thyroid disorder and pheochromocytoma), autoimmune diseases, and nutritional deficiencies (selenium and thiamine). It is characterized by thinning of the left ventricle, a dilated left ventricle or biventricular dilatation, left ventricular systolic dysfunction, left ventricular diastolic dysfunction, global hypokinesia, and cardiomegaly (seen on a chest X-ray). Decreased cardiac output leads to fatigue, cachexia, narrow pulse pressure, dicrotic pulse/hypokinetic pulse, dyspnea, cool extremities, decreased blood supply to the brain (cognitive dysfunction), and reduced blood supply to the kidney (renal failure). Left ventricular diastolic dysfunction can result in dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. Cardiomyopathy can also occur with or without left ventricular dysfunction, as in left ventricular non-compaction cardiomyopathy (LVNC), which is a rare heart disease occurring due to two (likely) pathogenic nonsense mutations: DSG2-p.S363X and TBX20-p.D278X. The study of familial forms of LVNC is helpful for risk prediction and genetic counseling of relatives. Right ventricular chamber failure can be identified on the electrocardiogram as sinus tachycardia and non-specific ST/T changes. The complications include arrhythmia (atrial fibrillation) and thromboembolism (left ventricular mural thrombosis). It is of utmost importance in the field of heart transplantation as the definitive treatment of the disease. Heart transplantation is now an acceptable treatment option for patients with dilated cardiomyopathy. This short review highlights different methods for the detection and diagnosis of dilated cardiomyopathy and the treatment modalities available for the same.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Mitral Valve Prolapse II: Assessment and Management

